Fetal Genome Screening Could Prove Tragic
By Scientific American,
Scientific American
| 01. 18. 2013
In a few years you will be able to order a transcript of your entire genetic code for less than $1,000. Adults cannot do much to alter their biological lot, but what if parents could examine their unborn child's genome? Without proper guidance, they might decide to take drastic measures—even to end the pregnancy—based on a misguided reading of the genetic tea leaves.
Two different university laboratories have developed tests that will reveal the entirety of a fetus's genetic code using just a blood sample from the mother (or that sample plus a drop of saliva from the father). Prenatal whole-genome sequencing will provide volumes of information beyond the currently available tests for genetic disorders such as Down's syndrome or Tay-Sachs disease—assays that parents now use to decide how to respond to a pregnancy. The three billion units of code furnished in the new tests will also dwarf the relative trickle of information provided by consumer gene-testing services such as 23andMe, which currently look (postnatally) only at perhaps about one million locations in the genome.
Any woman who undergoes such...
Related Articles
By Kevin Davies , Genetic Engineering and Biotechnology News | 10.22.2024
By Tomoko Otake, The Japan Times | 10.17.2024
Screening embryos during in-vitro fertilization to select those with fewer genetic risks for common diseases and certain physical traits is technologically and ethically questionable, a group of researchers have said in a new study.
The Japan Society of Obstetrics and...
By Ruha Benjamin, Los Angeles Review of Books | 10.18.2024
IN THE FALL OF 2016, I gave a talk at the Institute for Advanced Study in Princeton titled “Are Robots Racist?” Headlines such as “Can Computers Be Racist? The Human-Like Bias of Algorithms,” “Artificial Intelligence’s White Guy Problem,” and “Is...
By Hannah Devlin, Tom Burgis, David Pegg, and Jason Wilson, The Guardian [cites CGS’ Katie Hasson] | 10.18.2024
A US startup company is offering to help wealthy couples screen their embryos for IQ using controversial technology that raises questions about the ethics of genetic enhancement.
The company, Heliospect Genomics, has worked with more than a dozen couples undergoing...